Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCS-01 in Acute Ischemic Stroke
NCT03915431Phase 2Active, not recruiting
- Sponsor
- NC Medical Research
- Start
- Feb 2020
- Primary completion
- Oct 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of NCS-01 in ischemic stroke (2 arms), sponsored by NC Medical Research. Primary endpoints: Number of participants with adverse events at Month 12, National Institutes of Health Stroke Scale at 6 hours and 3 more. Started Feb 2020; status: active, not recruiting.
02
Drugs
NCS-01
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03915431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915431.